A detailed history of Lord, Abbett & Co. LLC transactions in Insulet Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 18,400 shares of PODD stock, worth $4.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,400
Previous 18,400 -0.0%
Holding current value
$4.84 Million
Previous $4.28 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$180.69 - $239.01 $3.32 Million - $4.4 Million
18,400 New
18,400 $4.28 Million
Q2 2023

Oct 07, 2024

SELL
$272.48 - $330.23 $22 Million - $26.6 Million
-80,598 Reduced 39.17%
125,178 $36.1 Million
Q2 2023

Aug 14, 2023

SELL
$272.48 - $330.23 $22 Million - $26.6 Million
-80,598 Reduced 39.17%
125,178 $36.1 Million
Q1 2023

Oct 07, 2024

SELL
$276.36 - $326.03 $43.2 Million - $51 Million
-156,476 Reduced 43.2%
205,776 $65.6 Million
Q1 2023

May 12, 2023

SELL
$276.36 - $326.03 $43.2 Million - $51 Million
-156,476 Reduced 43.2%
205,776 $65.6 Million
Q4 2022

Oct 07, 2024

BUY
$212.22 - $313.46 $76.9 Million - $114 Million
362,252 New
362,252 $107 Million
Q4 2022

Feb 10, 2023

BUY
$212.22 - $313.46 $13.5 Million - $19.9 Million
63,433 Added 21.23%
362,252 $107 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $58.2 Million - $72.9 Million
259,089 Added 652.12%
298,819 $68.5 Million
Q2 2022

Aug 12, 2022

BUY
$186.4 - $279.02 $28,519 - $42,690
153 Added 0.39%
39,730 $8.66 Million
Q1 2022

May 13, 2022

SELL
$194.8 - $275.7 $1.51 Million - $2.14 Million
-7,767 Reduced 16.41%
39,577 $10.5 Million
Q4 2021

Feb 11, 2022

BUY
$255.32 - $318.29 $1.43 Million - $1.78 Million
5,599 Added 13.41%
47,344 $12.6 Million
Q3 2021

Nov 09, 2021

SELL
$260.36 - $307.27 $42 Million - $49.6 Million
-161,284 Reduced 79.44%
41,745 $11.9 Million
Q2 2021

Aug 11, 2021

SELL
$225.52 - $304.06 $72.3 Million - $97.5 Million
-320,558 Reduced 61.22%
203,029 $55.7 Million
Q1 2021

May 11, 2021

BUY
$235.95 - $293.05 $35.6 Million - $44.2 Million
150,748 Added 40.43%
523,587 $137 Million
Q4 2020

Feb 09, 2021

BUY
$215.97 - $265.89 $36.3 Million - $44.7 Million
168,163 Added 82.16%
372,839 $95.3 Million
Q3 2020

Nov 12, 2020

BUY
$192.55 - $236.59 $413,212 - $507,722
2,146 Added 1.06%
204,676 $48.4 Million
Q2 2020

Aug 14, 2020

SELL
$159.17 - $224.73 $24.1 Million - $34 Million
-151,207 Reduced 42.75%
202,530 $39.3 Million
Q1 2020

May 14, 2020

SELL
$130.01 - $216.44 $24.4 Million - $40.7 Million
-187,971 Reduced 34.7%
353,737 $58.6 Million
Q4 2019

Feb 14, 2020

BUY
$144.81 - $186.0 $8.95 Million - $11.5 Million
61,797 Added 12.88%
541,708 $92.7 Million
Q3 2019

Nov 14, 2019

BUY
$117.35 - $167.95 $34.1 Million - $48.9 Million
290,898 Added 153.9%
479,911 $79.2 Million
Q2 2019

Aug 14, 2019

BUY
$82.13 - $120.73 $639,874 - $940,607
7,791 Added 4.3%
189,013 $22.6 Million
Q1 2019

May 15, 2019

SELL
$72.44 - $101.87 $15 Million - $21.1 Million
-207,378 Reduced 53.37%
181,222 $17.2 Million
Q4 2018

Feb 14, 2019

SELL
$73.27 - $105.19 $48.9 Million - $70.2 Million
-667,154 Reduced 63.19%
388,600 $30.8 Million
Q3 2018

Nov 14, 2018

BUY
$81.43 - $108.13 $1.66 Million - $2.21 Million
20,443 Added 1.97%
1,055,754 $112 Million
Q2 2018

Aug 14, 2018

SELL
$83.27 - $101.93 $14.5 Million - $17.7 Million
-173,550 Reduced 14.36%
1,035,311 $88.7 Million
Q1 2018

May 15, 2018

BUY
$68.49 - $87.2 $2.33 Million - $2.97 Million
34,025 Added 2.9%
1,208,861 $105 Million
Q4 2017

Feb 14, 2018

BUY
$55.67 - $71.8 $12.1 Million - $15.6 Million
216,628 Added 22.61%
1,174,836 $81.1 Million
Q3 2017

Nov 14, 2017

BUY
$49.68 - $59.46 $5.96 Million - $7.13 Million
119,906 Added 14.3%
958,208 $52.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
838,302
838,302 $43 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.